These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group. Talwalkar JA; Seaberg E; Kim WR; Wiesner RH Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Wiesner RH Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898 [TBL] [Abstract][Full Text] [Related]
9. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330 [TBL] [Abstract][Full Text] [Related]
10. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A; Glaumann H; Persson B; Broomé U Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Wiesner RH; Porayko MK; Hay JE; LaRusso NF; Steers JL; Krom RA; Dickson ER Liver Transpl Surg; 1996 Sep; 2(5 Suppl 1):99-108. PubMed ID: 9346709 [TBL] [Abstract][Full Text] [Related]
12. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560 [TBL] [Abstract][Full Text] [Related]
13. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Tischendorf JJ; Hecker H; Krüger M; Manns MP; Meier PN Am J Gastroenterol; 2007 Jan; 102(1):107-14. PubMed ID: 17037993 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Brandsaeter B; Broomé U; Isoniemi H; Friman S; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Olsson R; Olausson M; Kirkegaard P; Bjøro K Liver Transpl; 2003 Sep; 9(9):961-9. PubMed ID: 12942458 [TBL] [Abstract][Full Text] [Related]
15. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Kim WR; Poterucha JJ; Wiesner RH; LaRusso NF; Lindor KD; Petz J; Therneau TM; Malinchoc M; Dickson ER Hepatology; 1999 Jun; 29(6):1643-8. PubMed ID: 10347102 [TBL] [Abstract][Full Text] [Related]